MBOT
Income statement / Annual
Last year (2024), Microbot Medical Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Microbot Medical Inc.'s net income was -$11.44 M.
See Microbot Medical Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$117.00 K |
| Cost of Revenue |
$91.00 K
|
$106.00 K
|
$0.00
|
$0.00
|
$0.00
|
$84.00 K
|
$54.00 K
|
$21.00 K
|
$10.00 K
|
$17.00 K
|
| Gross Profit |
-$91.00 K
|
-$106.00 K
|
$0.00
|
$0.00
|
$0.00
|
-$84.00 K
|
-$54.00 K
|
-$21.00 K
|
-$10.00 K
|
$117.00 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
| Research and Development Expenses |
$6.63 M
|
$5.72 M
|
$7.74 M
|
$6.15 M
|
$3.40 M
|
$2.97 M
|
$2.86 M
|
$1.28 M
|
$1.11 M
|
$823.00 K
|
| General & Administrative Expenses |
$5.00 M
|
$4.13 M
|
$5.58 M
|
$5.20 M
|
$5.69 M
|
$0.00
|
$4.71 M
|
$4.14 M
|
$8.73 M
|
$92.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$206.00 K
|
$195.00 K
|
$0.00
|
$23.00 K
|
$17.00 K
|
$36.00 K
|
$9.24 M
|
| Selling, General & Administrative Expenses |
$5.00 M
|
$4.13 M
|
$5.58 M
|
$5.41 M
|
$5.89 M
|
$4.18 M
|
$4.73 M
|
$4.20 M
|
$8.77 M
|
$9.33 M
|
| Other Expenses |
-$91.00 K
|
-$106.00 K
|
-$36.00 K
|
-$206.00 K
|
-$195.00 K
|
$0.00
|
-$476.00 K
|
-$213.00 K
|
-$249.00 K
|
-$230.00 K
|
| Operating Expenses |
$11.53 M
|
$9.75 M
|
$13.28 M
|
$11.36 M
|
$9.09 M
|
$7.16 M
|
$7.24 M
|
$5.27 M
|
$9.64 M
|
$915.00 K
|
| Cost And Expenses |
$11.63 M
|
$9.86 M
|
$13.28 M
|
$11.36 M
|
$9.09 M
|
$7.24 M
|
$7.24 M
|
$5.27 M
|
$9.64 M
|
$36.45 M
|
| Interest Income |
$182.00 K
|
$228.00 K
|
$54.00 K
|
$44.00 K
|
$80.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$7.54 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$80.00 K
|
$103.00 K
|
$0.00
|
$238.00 K
|
$334.00 K
|
$506.32 K
|
| Depreciation & Amortization |
$91.00 K
|
$106.00 K
|
$102.00 K
|
$76.00 K
|
$68.00 K
|
$84.00 K
|
$54.00 K
|
$21.00 K
|
$10.00 K
|
$1.13 M
|
| EBITDA |
-$11.35 M |
-$10.63 M |
-$13.34 M |
-$11.28 M |
-$9.02 M |
-$7.06 M |
-$7.17 M |
-$5.25 M |
-$9.63 M |
-$36.61 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-312.91
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-313.85
|
| Total Other Income/Expenses Net |
$182.00 K
|
-$885.00 K
|
$113.00 K
|
$44.00 K
|
-$80.00 K
|
-$7.00 K
|
-$16.00 K
|
-$2.32 M
|
-$28.00 K
|
-$6.00 K
|
| Income Before Tax |
-$11.44 M
|
-$10.74 M
|
-$13.17 M
|
-$11.31 M
|
-$9.17 M
|
-$7.25 M
|
-$7.26 M
|
-$7.59 M
|
-$9.66 M
|
-$36.41 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-311.23
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$20.00 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.44 M
|
-$10.74 M
|
-$13.17 M
|
-$11.31 M
|
-$9.17 M
|
-$7.25 M
|
-$7.26 M
|
-$7.59 M
|
-$9.66 M
|
-$36.42 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-311.24
|
| EPS |
-0.73 |
-1.05 |
-1.81 |
-1.59 |
-1.29 |
-1.7 |
-0.81 |
-0.85 |
-10.14 |
-12.58 |
| EPS Diluted |
-0.73 |
-1.05 |
-1.81 |
-1.59 |
-1.29 |
-1.7 |
-0.81 |
-0.85 |
-10.14 |
-7.2 |
| Weighted Average Shares Out |
$15.65 M
|
$10.20 M
|
$7.26 M
|
$7.11 M
|
$7.12 M
|
$4.27 M
|
$8.92 M
|
$8.92 M
|
$952.89 K
|
$73.24 K
|
| Weighted Average Shares Out Diluted |
$15.65 M
|
$10.20 M
|
$7.26 M
|
$7.11 M
|
$7.12 M
|
$4.27 M
|
$8.92 M
|
$8.92 M
|
$952.89 K
|
$73.24 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
